Back To: Home

Our 2019 Media Kit is now available
Your gateway to the latest oncology news, trends and resources
Inside this issue:
November 2018
Company has high hopes for antibody candidates targeting toxic oligomers...
by Kristen Smith
November 2018
Themis Bioscience plans to expand measles vector immunomodulation portfolio into oncology indications...
by Mel J. Yeates
November 2018
Study reveals that ‘traditional digital advertising rules don’t apply’ in clinical trial recruitment...
by Jeffrey Bouley
November 2018
Cancer characterization breakthroughs lead to advances in understanding of and techniques for fetal monitoring...
by Randall C Willis

Patent Docs:
Obviousness remains an uncertain patentability standard
Public policy regarding innovator drug products need regulatory exclusivities outside mere patent protection in order to provide necessary incentive for further pharmaceutical innovation

Editor's Focus:
November 2018
When differences in genetic variants are accounted for in clinical trial design, interventional trials can become much more successful for particular patient groups.. [ more ]
by Jill Johnston & Karmen Trzupek

November 2018
There is an increasing shift with pharma/biotech researchers and execs not just speaking about platforms and performance but also focusing more intently on people and impacts on daily lives.. [ more ]
by Randall C Willis

November 2018
Are price controls the best way to rein in drug costs, or do we perhaps need to dig deeper into the issue of what is required to bring drugs to market to begin with?.. [ more ]
by Jeffrey Bouley

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by Offenberger & White.